title: A Portuguese patient homozygous for the -25G>A mutation of the HAMP promoter shows evidence of steady-state transcription but fails to up-regulate hepcidin levels by iron.
authors.forename: Graça
authors.initials: G
authors.lastname: Porto
authors.forename: Antonella
authors.initials: A
authors.lastname: Roetto
authors.forename: Filomena
authors.initials: F
authors.lastname: Daraio
authors.forename: Jorge Pereira
authors.initials: JP
authors.lastname: Pinto
authors.forename: Susana
authors.initials: S
authors.lastname: Almeida
authors.forename: Conceição
authors.initials: C
authors.lastname: Bacelar
authors.forename: Elizabeth
authors.initials: E
authors.lastname: Nemeth
authors.forename: Tomas
authors.initials: T
authors.lastname: Ganz
authors.forename: Clara
authors.initials: C
authors.lastname: Camaschella
mesh_terms: D023181:Antimicrobial Cationic Peptides / Q000235:genetics* / Q000652:urine; D005998:Glycine / Q000235:genetics*; D006432:Hemochromatosis / Q000235:genetics; D064451:Hepcidins; D006720:Homozygote; D006801:Humans; D007501:Iron / Q000494:pharmacology*; D009154:Mutation / Q000235:genetics; D011174:Portugal; D011401:Promoter Regions, Genetic / Q000235:genetics*; D014158:Transcription, Genetic / Q000235:genetics*; D015854:Up-Regulation / Q000187:drug effects*
chemical_list: D023181:Antimicrobial Cationic Peptides; C578702:HAMP protein, human; D064451:Hepcidins; D007501:Iron; D005998:Glycine